CSMG Technologies Reviews Last 12 Months at Empire Financial Group Conference.

Live Tissue Connect Subsidiary Attains Key Strategic Milestones

CORPUS CHRISTI, Texas -- CSMG Technologies, Inc., (OTCBB: CTUM), a technology management company focused on commercializing human live tissue surgical bonding devices, announced updating its investment banking firm, Empire Financial Group (Amex: EFH), at Empire's annual Key Producers Meeting one year after EFH was retained, and was successful in funding the Company.

CSMG President and CEO Donald S. Robbins informed the representatives of Empire that in the past year since Empire started funding CSMG to commercialize CSMG's tissue welding technology. We have attained a number of important, key accomplishments during the last 12 months, among them:

* Hired Frank D'Amelio, an internationally recognized medical device expert, to lead the commercialization of our patented surgical device for bonding live human tissue.

* Hired Stellartech, a leading surgical device design company, to design and manufacture the LTC commercial electro-surgery generator, and ViR and Ventrex, leading instrument designers and manufacturers, to design and manufacture the disposable instruments.

* Retained a major U.S. University to complete important laboratory work

* Completed the duct and vessel sealing procedure equipment for FDA filing

* Retained a leading Washington, DC law firm specializing in FDA filings

* Filed a 510(K) submission with the U.S. FDA for the duct and vessel sealer and two instruments.

* Identified 13 surgical specific procedure license and distribution opportunities, and of these have formed 5 surgical procedure specific subsidiaries under subsidiary Live Tissue Connect (LTC)

* Nearly completed end-to-end anastomosis prototype and testing in Ukraine

* Engaged an international research firm to audit Ukraine human surgeries

* Currently preparing documentation for Europe's CE Mark certification

* Added two key surgeons to the U.S. advisory group to provide surgeon training and surgical feedback

* Have 29 surgeons, engineers and scientists working on the LTC project in Ukraine

* Have five engineers in the United States working on product commercialization

* Had European Union, Ukraine, and Canadian patents issued, which supplement the exiting U.S. and Australian patents already issued

Mr. Robbins also informed the Empire representatives that CSMG had 40 US and international issued or pending.

"We have enjoyed working with Empire Financial Group, as they understand our technologies, and importantly, have a successful track record raising capital. Over this last 12 month period CSMG's market cap has grown from $8.25 million to about $26.4 million, while we reduced debt by approximately $400 thousand," added Mr. Robbins.

Mr. Ed Cabrera, Senior Managing Director of Investment Banking, Empire Financial Group said, "We are proud of our association with CSMG, and continue to believe that it owns a truly disruptive technology that has the potential to alter surgical procedures."

About Empire Financial Group, Inc.

Empire Financial Group and its subsidiaries provide investment banking and corporate financing services, as well as securities brokerage, asset management, and market making services in the United States, Europe and Asia. It provides brokerage services directly to retail customers, and small- to mid-sized institutions. Empire Investment Advisors provides investment advisory services to its customers, independent registered investment advisors, and unaffiliated broker dealers. Empire Financial Holding also offers ancillary services, including market data and financial information, portfolio tracking and records management, cash management services, and account security. Based in Longwood, Florida, the company, founded in 2000, has offices in NYC, NY and other locations throughout the U.S.

About CSMG Technologies, Inc.

CSMG Technologies is a technology management company that finances, owns, develops, licenses and markets innovative advanced technologies and business opportunities created in the Ukraine through a network of scientific institutes and private organizations. CSMG is focused on two primary subsidiaries, Live Tissue Connect, Inc. and landfill gas processing.

Information regarding procedures using the technology and technical information regarding the technology will be removed from our web site pending FDA clearance. For further information on CSMG Technologies and its various subsidiaries, please visit our website at www.ctum.com.

Sign up to receive CSMG Technologies automated email press releases and other notifications: Please go to http://www.ctum.com/contact_information.html and fill-in information.

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934 as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.